POSITRIGO

Imaging Everyone

POSITRIGO was founded in 2018, is headquartered in Zurich, Switzerland, lists 11–50 employees, and has $15.6M in recorded funding across 2 rounds.

Headquarters
Zurich
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$15.6M
Last Round
$8.7M Venture RoundJun 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Positrigo, headquartered in Zurich, Switzerland, was founded in 2018 as a spin-off of ETH Zurich. The company develops NeuroLF, an ultra-compact, dedicated brain Positron Emission Tomography (PET) scanner that makes functional brain imaging accessible for diagnosing Alzheimer's disease, dementia, neuro-oncology, epilepsy, and movement disorders. NeuroLF has received both FDA clearance and CE Mark, and Positrigo has expanded into the U.S. and multiple European markets.

Summary

POSITRIGO is a Biotech company based in Zurich, Switzerland, founded in 2018. It lists 11–50 employees. It has raised $15.6M in total across 2 rounds, most recently a $8.7M Venture Round in Jun 2025. Investors include HealthCap, EIC Fund and Zürcher Kantonalbank.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundFinancing RoundJun 2025
$8.7M

Sign up to see all 2 events

Funding: Series B through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

POSITRIGO on Indexed.vc
<a href="https://indexed.vc/companies/positrigo"><img src="https://indexed.vc/api/badge/company/positrigo" alt="POSITRIGO on Indexed.vc" width="260" height="76" /></a>